Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 23% ± 6% |
Insufficient scRNA-seq data for expression of MYORG at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 99% | 3826.57 | 357 / 359 | 99% | 41.61 | 283 / 286 |
brain | 100% | 4936.84 | 2634 / 2642 | 98% | 44.73 | 691 / 705 |
liver | 99% | 5264.69 | 223 / 226 | 99% | 42.13 | 401 / 406 |
intestine | 97% | 4668.05 | 935 / 966 | 99% | 39.57 | 520 / 527 |
pancreas | 98% | 1779.74 | 320 / 328 | 95% | 22.22 | 169 / 178 |
esophagus | 95% | 2325.50 | 1378 / 1445 | 95% | 30.27 | 174 / 183 |
kidney | 93% | 1779.80 | 83 / 89 | 83% | 11.96 | 745 / 901 |
breast | 73% | 998.51 | 337 / 459 | 96% | 26.36 | 1070 / 1118 |
adrenal gland | 95% | 1877.65 | 245 / 258 | 54% | 10.26 | 124 / 230 |
bladder | 67% | 778.48 | 14 / 21 | 80% | 16.74 | 402 / 504 |
lung | 54% | 515.24 | 310 / 578 | 87% | 17.28 | 1010 / 1155 |
uterus | 46% | 594.14 | 79 / 170 | 86% | 15.09 | 394 / 459 |
skin | 50% | 500.21 | 900 / 1809 | 56% | 7.52 | 266 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.01 | 1 / 1 |
muscle | 99% | 9463.79 | 796 / 803 | 0% | 0 | 0 / 0 |
ovary | 7% | 149.27 | 13 / 180 | 89% | 18.23 | 383 / 430 |
prostate | 56% | 666.68 | 136 / 245 | 36% | 2.77 | 181 / 502 |
adipose | 80% | 1272.08 | 967 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 11.53 | 36 / 45 |
blood vessel | 59% | 909.35 | 785 / 1335 | 0% | 0 | 0 / 0 |
thymus | 35% | 333.70 | 229 / 653 | 22% | 1.94 | 134 / 605 |
heart | 47% | 443.41 | 404 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 20% | 1.61 | 16 / 80 |
spleen | 1% | 12.21 | 3 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.47 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048741 | Biological process | skeletal muscle fiber development |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0043568 | Biological process | positive regulation of insulin-like growth factor receptor signaling pathway |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004553 | Molecular function | hydrolase activity, hydrolyzing O-glycosyl compounds |
Gene name | MYORG |
Protein name | Myogenesis regulating glycosidase (putative) Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161) |
Synonyms | KIAA1161 |
Description | FUNCTION: Putative glycosidase. Promotes myogenesis by activating AKT signaling through the maturation and secretion of IGF2. . |
Accessions | X6RA92 ENST00000379142.3 ENST00000297625.8 Q6NSJ0 |